Active surveillance study for men at higher risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial studies how well “active surveillance” works for men with prostate cancer who are considered higher risk because of family history or genetics. It aims to safely monitor the cancer and decide the best timing for treatment if needed, while tracking side effects and follow-up success.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man age 18 or older, and be followed by an active surveillance clinic.
- You must already have a confirmed diagnosis of prostate cancer, and your care team must agree it’s suitable for active surveillance at a team meeting.
- You must fit at least one higher-risk category: strong family history, Black African/Black African-Caribbean ancestry, a known cancer-risk gene change, or other high genetic risk.
- If you’re in the study control group, you must have low-grade prostate cancer and no known high-risk gene factors, also approved for active surveillance by the team meeting.
- You must be able to attend follow-up visits as planned and not have major psychological or social situations that could make follow-up difficult.
- You must have no significant psychological condition that could worsen with study participation. (Also, you must have a prostate cancer diagnosis—no prostate cancer means no enrollment.)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how inherited risk (family history or gene findings) relates to screening and treatment for prostate cancer. If you qualify, you may be offered prostate screening tests and follow-up to see how well risk information predicts next steps.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This study tries to personalize prostate cancer care by matching treatment decisions to a person’s specific risk profile. You might be able to join if you have certain types of prostate cancer or a strong family history and meet health-function requirements.
This study looks at how prostate cancer diagnoses and treatments turn out over time. It compares men who carry rare inherited gene changes that raise prostate cancer risk with men who do not, to better understand which treatments and outcomes may differ.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.